Stimulationtime (h) | Term | Gene count | P-Value |
4 | Type I diabetes mellitus | 5 | 3.0E−4 |
Ribosome | 6 | 5.4E−4 | |
Viral myocarditis | 5 | 2.2E−3 | |
Allograft rejection | 4 | 2.7E−3 | |
Graft-versus-host disease | 4 | 3.4E−3 | |
Autoimmune thyroid disease | 4 | 7.2E−2 | |
Cell adhesion molecules | 5 | 1.9E−2 | |
Intestinal immune network for IgA production | 3 | 5.6E−2 | |
| Natural killer cell modified cytotoxicity | 4 | 8.6E−2 |
8 | Terpenoid backbone biosynthesis | 2 | 3.2E−2 |
| Allograft rejection | 2 | 7.5E−2 |
Graft-versus-host disease | 2 | 8.1E−2 | |
| Type I diabetes mellitus | 2 | 8.7E−2 |
12 | Ribosome | 4 | 1.4E−3 |
Valine, leucine and isoleucine degradation | 3 | 2.7E−2 | |
| Terpenoid backbone biosynthesis | 2 | 8.5E−2 |
24 | n.p | - | - |